• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
OTC Pharmaceuticals in Denmark Product Image

OTC Pharmaceuticals in Denmark

  • Published: November 2010
  • Region: Denmark
  • 44 pages
  • Datamonitor

FEATURED COMPANIES

  • GlaxoSmithKline Plc
  • Novartis AG
  • Pfizer Inc
  • MORE

The OTC Pharmaceuticals in Denmark industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

- Contains an executive summary and data on value, volume and/or segmentation

- Provides textual analysis of OTC Pharmaceuticals in Denmark’s recent performance and future prospects

- Incorporates in-depth five forces competitive environment analysis and scorecards

- Includes a five-year forecast of OTC Pharmaceuticals in Denmark

- The leading companies are profiled with supporting key financial metrics

- Supported by the key macroeconomic and demographic data affecting the market

Highlights

- Detailed information is included on market size, measured by both value and volume

- Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

- Market shares are covered by manufacturer and/or brand

- Also features market breakdown READ MORE >

EXECUTIVE SUMMARY
MARKET OVERVIEW
Market definition
Research highlights
Market analysis
MARKET VALUE
MARKET SEGMENTATION I
MARKET SEGMENTATION II
MARKET SHARE
FIVE FORCES ANALYSIS
Summary
Buyer power
Supplier power
New entrants
Substitutes
Rivalry
LEADING COMPANIES
Johnson & Johnson
Novartis AG
GlaxoSmithKline Plc
MARKET DISTRIBUTION
MARKET FORECASTS
Market value forecast
MACROECONOMIC INDICATORS
APPENDIX
Methodology
Industry associations
Related Datamonitor research
Disclaimer
ABOUT DATAMONITOR
Premium Reports
Summary Reports
Datamonitor consulting

LIST OF TABLES
Table 1: Denmark OTC pharmaceuticals market value: $ million, 2005–09
Table 2: Denmark OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 3: Denmark OTC pharmaceuticals market segmentation II: % share, by value, 2009
Table 4: Denmark OTC pharmaceuticals market share: % share, by value, 2009
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: key financials ($)
Table 7: Johnson & Johnson: key financial ratios
Table 8: Novartis AG: key facts
Table 9: Novartis AG: key financials ($)
Table 10: Novartis AG: key financial ratios
Table 11: GlaxoSmithKline Plc: key facts
Table 12: GlaxoSmithKline Plc: key financials ($)
Table 13: GlaxoSmithKline Plc: key financials (£)
Table 14: GlaxoSmithKline Plc: key financial ratios
Table 15: Denmark OTC pharmaceuticals market distribution: % share, by value, 2009
Table 16: Denmark OTC pharmaceuticals market value forecast: $ million, 2009–14
Table 17: Denmark size of population (million), 2005–09
Table 18: Denmark gdp (constant 2000 prices, $ billion), 2005–09
Table 19: Denmark gdp (current prices, $ billion), 2005–09
Table 20: Denmark inflation, 2005–09
Table 21: Denmark consumer price index (absolute), 2005–09
Table 22: Denmark exchange rate, 2005–09

LIST OF FIGURES
Figure 1: Denmark OTC pharmaceuticals market value: $ million, 2005–09
Figure 2: Denmark OTC pharmaceuticals market segmentation I:% share, by value, 2009
Figure 3: Denmark OTC pharmaceuticals market segmentation II: % share, by value, 2009
Figure 4: Denmark OTC pharmaceuticals market share: % share, by value, 2009
Figure 5: Forces driving competition in the OTC pharmaceuticals market in Denmark, 2009
Figure 6: Drivers of buyer power in the OTC pharmaceuticals market in Denmark, 2009
Figure 7: Drivers of supplier power in the OTC pharmaceuticals market in Denmark, 2009
Figure 8: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Denmark, 2009
Figure 9: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Denmark, 2009
Figure 10: Drivers of degree of rivalry in the OTC pharmaceuticals market in Denmark, 2009
Figure 11: Johnson & Johnson: revenues & profitability
Figure 12: Johnson & Johnson: assets & liabilities
Figure 13: Novartis AG: revenues & profitability
Figure 14: Novartis AG: assets & liabilities
Figure 15: GlaxoSmithKline Plc: revenues & profitability
Figure 16: GlaxoSmithKline Plc: assets & liabilities
Figure 17: Denmark OTC pharmaceuticals market distribution: % share, by value, 2009
Figure 18: Denmark OTC pharmaceuticals market value forecast: $ million, 2009–14



- GlaxoSmithKline Plc
- Novartis AG
- Pfizer Inc

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos